But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

The next chapter of the right-wing war on the Affordable Care Act involves a case that targets the preventative care that ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...

Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...

Among treatment-naive people with HIV, dolutegravir/lamivudine showed viral suppression comparable with those of other ...

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

Every week, 4000 young women contract HIV. Discover hidden barriers to prevention and innovative solutions that can change ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.